Entasis Therapeutics Holdings Inc. (ETTX) has 20 open-market insider trades by 17 insiders since 2018. The most active filer is Innoviva, Inc., Director & 10% Owner.
| Name | Title | Tier | Trades | Value | Last Trade |
|---|---|---|---|---|---|
| Innoviva Strategic Opportunities LLC | 10% Owner | — | 2 | $97.3M | 2022-07-11 |
| Innoviva, Inc. | Dir10% Owner | — | 3 | $64.2M | 2021-05-03 |
| Novo Holdings A/S | 10% Owner | — | 1 | $16.3M | 2018-09-28 |
| Nicholas Galakatos | Dir10% Owner | — | 1 | $6.8M | 2018-09-28 |
| Patrick J. Heron | 10% Owner | — | 1 | $5.6M | 2018-09-28 |
| James N. Topper | Dir10% Owner | — | 1 | $5.6M | 2018-09-28 |
| Heather Preston | Dir10% Owner | — | 1 | $5.1M | 2018-09-28 |
| Michael Powell | 10% Owner | — | 1 | $5.1M | 2018-09-28 |
| David Bonderman | 10% Owner | — | 1 | $3.9M | 2018-09-28 |
| Astrazeneca PLC | 10% Owner | — | 1 | $3.7M | 2018-09-28 |
| Insider | Title | Type | Value | Date |
|---|---|---|---|---|
| Innoviva Strategic Opportunities LLC | 10% Owner | Buy | $84.8M | 2022-07-08 |
| Michael Gutch | — | Sell | $12K | 2021-10-19 |
| John Patrick Mueller | Chief Development Officer | Sell | $13K | 2021-10-19 |
| Manoussos Perros | — | Sell | $38K | 2021-10-19 |
| Innoviva Strategic Opportunities LLC | 10% Owner | Buy | $12.5M | 2021-06-11 |
| Innoviva, Inc. | Director & 10% Owner | Buy | $7.5M |
Companies that share insiders with ETTX, and sector peers with recent insider buying. Related by who files, not by how the stocks move.
| 2021-05-03 |
| Innoviva, Inc. | 10% Owner | Buy | $25.0M | 2020-09-01 |
| Innoviva, Inc. | 10% Owner | Buy | $31.7M | 2020-06-11 |
| FHM LIFE Sciences Viii, L.P. | 10% Owner | Sell | $250K | 2020-01-09 |
| Nicholas Galakatos | Director & 10% Owner | Buy | $6.8M | 2018-09-28 |
| Astrazeneca PLC | 10% Owner | Buy | $3.7M | 2018-09-28 |
| Michael Powell | 10% Owner | Buy | $5.1M | 2018-09-28 |
| Novo Holdings A/S | 10% Owner | Buy | $16.3M | 2018-09-28 |
| David Bonderman | 10% Owner | Buy | $3.9M | 2018-09-28 |
| Patrick J. Heron | 10% Owner | Buy | $5.6M | 2018-09-28 |